Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis

[1]  S. Kimura,et al.  Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. , 2020, Blood advances.

[2]  Yoshiya Tanaka,et al.  Five Cases of IgG4-related Disease with Nasal Mucosa and Sinus Involvement , 2020, Internal medicine.

[3]  J. Cohen,et al.  Chronic Active Epstein–Barr Virus Disease , 2017, Front. Immunol..

[4]  H. Tagawa,et al.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features , 2017, Haematologica.

[5]  M. Hamazaki,et al.  Chronic active EBV infection with features of granulomatosis with polyangiitis , 2016, Pediatrics international : official journal of the Japan Pediatric Society.

[6]  Sin-Ho Jung,et al.  A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. , 2016, The Lancet. Oncology.

[7]  Bruce D Cheson,et al.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Jihao Ren,et al.  Aggressive Sinonasal Natural Killer/T-cell Lymphoma Mimicking Refractory Sinusitis In A 4-Year-Old Boy , 2012, Fetal and pediatric pathology.

[9]  T. Naoe,et al.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. , 2012, Blood.

[10]  K. Kawa,et al.  Clinicopathological analysis of the age‐related differences in patients with Epstein–Barr virus (EBV)‐associated extranasal natural killer (NK)/T‐cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection‐associated lymphoproliferative disorde , 2011, Histopathology.

[11]  W. Wilson,et al.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. , 2011, Blood.

[12]  C. Nakaseko,et al.  Clinical features of adult-onset chronic active Epstein–Barr virus infection: a retrospective analysis , 2011, International journal of hematology.

[13]  H. Kimura.  Pathogenesis of chronic active Epstein‐Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? , 2006, Reviews in medical virology.

[14]  R. Gascoyne,et al.  Evidence for Early Infection of Nonneoplastic Natural Killer Cells by Epstein-Barr Virus , 2002, Journal of Virology.

[15]  Y. Sakiyama,et al.  Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. , 2001, Blood.

[16]  J. Itami,et al.  Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Sedaghat.  Chronic Rhinosinusitis. , 2017, American family physician.